Key takeaways
Xtandi (enzalutamide) and Eulexin (flutamide) are both oral medications used to treat metastatic prostate cancer, but they have some key differences. Xtandi is taken once a day, while Eulexin is taken three times a day. Both medications require combination therapy with other hormonal treatments, however, Eulexin usually only needs to be taken for a few weeks after starting a LHRH agonist. Common side effects while on Xtandi are weakness and back pain, while people taking Eulexin commonly experience hot flashes and loss of sex drive. Additionally, Xtandi can cause serious side effects like seizures and heart problems, whereas Eulexin can lead to severe liver damage and increased bleeding risk if taken with warfarin. Xtandi is a newer medication and is only available as a brand, making it more expensive, while Eulexin is available as a lower-cost generic.
